Rznomics, Rokit Healthcare Team Up on RNA-Based Anti-Aging Technology
Rznomics and Rokit Healthcare signed an MOU to combine circular RNA and regenerative medicine technology, targeting the anti-aging market through joint R&D and commercialization.
Read the full articleYou might also wanna read
The biotech bi-weekly: a disease modeling research grant and an accelerator program for data-driven health start-ups
In this edition of the biotech bi-weekly: a new companion module makes direct RNA sequencing protocols more convenient, antibiotic design an
Network-driven discovery of repurposable drugs targeting hallmarks of aging
Network-driven discovery of repurposable drugs targeting hallmarks of aging
Synergistic senolytic–regenerative therapy significantly extends healthspan and lifespan
Synergistic senolytic–regenerative therapy significantly extends healthspan and lifespan
Haya Therapeutics targets the dark genome to develop treatments for fibrotic disease
Samir Ounzain talks to C&EN about reprogramming cells by targeting the dark genome
cen.acs.org·27d agoJMIR Report: Machine Learning Accelerates Radiopharmaceutical Drug Discovery, Optimizes Personalized Dosimetry
JMIR Publications released a feature News and Perspectives story on technological advances in oncology.
Extracellular Vesicles as Anti-Aging Therapeutics: Mechanisms, Bioengineering, and Clinical Perspectives
This review systematically elucidates the multifactorial anti-aging mechanisms of extracellular vesicles (EVs). By bridging fundamental biol
onlinelibrary.wiley.com·22d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.